A Comparative Study of Intraperitoneal Carboplatin versus Intravenous Carboplatin with Intravenous Cyclophosphamide in Both Arms as Initial Chemotherapy for Stage III Ovarian Cancer

Publisher： Karger

E-ISSN： 1423-0232|56|4|291-296

ISSN： 0030-2414

Source： Oncology, Vol.56, Iss.4, 1999-05, pp. : 291-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dose Escalation of Carboplatin and Cyclophosphamide Supported by GM-CSF in the Treatment of Patients with Advanced Ovarian Cancer (FIGO III and IV) – a Phase I Study

By  

Oncology Research and Treatment, Vol. 22, Iss. 6, 2000-01 ,pp. : 502-506

Karger

Access to resources Recommend Favorite

Paclitaxel plus Carboplatin Chemotherapy for Primary Peritoneal Carcinoma: A Study of 22 Cases and Comparison with Stage III–IV Ovarian Serous Carcinoma

By  

Case Reports in Oncology, Vol. 5, Iss. 1, 2012-04 ,pp. : 173-180

Karger

Access to resources Recommend Favorite

A Risk-Adapted Strategy of Adjuvant Paclitaxel/Carboplatin in Early-Stage Ovarian Cancer: Time-Dependent Effect of 4 versus 6 Cycles on Outcome

By  

Oncology, Vol. 81, Iss. 5-6, 2012-01 ,pp. : 365-371

Karger

Access to resources Recommend Favorite

Intraperitoneal chemotherapy of ovarian cancer

By Lowe Thomas   Morgan Robert J  

Women's Health, Vol. 3, Iss. 4, 2007-07 ,pp. : 433-440

Future Medicine

Access to resources Recommend Favorite

Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus‐associated oropharyngeal squamous cell cancer

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 40, Iss. 2, 2018-02 ,pp. : 233-241

John Wiley & Sons Inc

Access to resources Recommend Favorite